A growth strategy focused on access, accretive opportunities, and ambulatory represents a new “Triple A” for hospitals and health systems.

On this week’s Monday interview, host J. Carlisle Larsen speaks with Kaufman Hall’s Scott Christensen about trends within the retail healthcare delivery space and what hospitals can learn from these organizations’ stumbles and successes.

In 2021, Carilion Clinic, a $2 billion revenue, eight-hospital integrated system in Roanoke, Virginia, was facing a problem familiar to many systems around the country: stubbornly high...

Trump picks his healthcare cabinet nominees, PBMs sue the FTC over its insulin case, and controlled substance telehealth flexibilities are extended yet again.

This week’s graphic highlights the increasing prominence of state-directed payment (SDP) arrangements for Medicaid programs nationwide.

Numerous headwinds in recent years have threatened liquidity, exposed organizations to counterparty risk, and heightened uncertainty about long-term financial sustainability. This report discusses six trends and related action steps to help position your organization for tomorrow’s Treasury Operations needs.

Recent efforts to contemporize primary care have proven that the best intentions, the smartest ideas, and a lot of money are no guarantee of commercial success. Corporate America has found primary care to be a confounding and, so far, unsuccessful business model.

Retailers have made a big splash in the healthcare delivery space over the last decade, but many have seen mixed success with their healthcare business. Some companies, including CVS...

Partnerships with imaging companies can offer a unique value proposition for health systems looking to blend their imaging offering between hospital outpatient department and independent diagnostic testing facility settings.

This week’s graphic illustrates how Epic has continued to expand its lead in the electronic health record (EHR) market over its rival Oracle Health, which acquired Cerner in 2022.

DOJ sues to block UHG-Amedisys deal, Cigna quashes Humana merger talks, and Johnson & Johnson sues to revive its 340B rebate program.